Epigenetics Market Size, Share, Growth & Industry Analysis, By Products & Services (Kits & Reagents, Enzymes, Instruments & Accessories, Software), By Application (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Others), By Technology (DNA Methylation, Histone Modification, NGS, Others), By End User and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL EPIGENETICS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY
2.1 RESEARCH METHODOLOGY
2.2 Data Collection
2.2.1 Secondary Sources
2.2.2 Primary Sources
2.2.3 Research Flow
2.3 Subject Matter Expert Advice
2.4 Quality Check
2.5 Final Review
2.6 Bottom-Up Approach
2.7 Top-down Approach

3 GLOBAL EPIGENETICS MARKET OUTLOOK
3.1 Market Evolution
3.2 Overview
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.3.4 Challenges
3.4 Pricing Analysis
3.5 Porter’s Five Forces Analysis
3.6 Value Chain Analysis
3.7 Macroeconomic Analysis

4 IMPACT OF RUSSIA-UKRAINE WAR

5 GLOBAL EPIGENETICS MARKET, BY PRODUCT & SERVICES
5.1 Overview
5.2 Kits & Reagents
5.3 Enzymes
5.4 Instruments & Accessories
5.5 Software
5.6 Services 

6 GLOBAL EPIGENETICS MARKET, BY APPLICATION
6.1 Overview
6.2 Oncology
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Diseases
6.5 Metabolic Disorders
6.6 Others

7 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY
7.1 Overview
7.2 DNA Methylation
7.3 Histone Modification
7.4 NGS
7.5 Others 

8 GLOBAL EPIGENETICS MARKET, BY END-USER
8.1 Overview
8.2 Academic & Research Institutes
8.3 Pharmaceutical & Biotechnology Companies
8.4 Diagnostic Labs
8.5 Hospitals & Clinics 

9 GLOBAL EPIGENETICS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL EPIGENETICS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Thermo Fisher Scientific Inc
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Illumina, Inc.
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 PacBio
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.4 Abcam Limited.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.5  Merck KGaA
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.6 Active Motif Inc.
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.6.5 Winning Imperatives
16.6.6 Current Focus & Strategies
16.6.7 Threat from competition
16.7 Bio-Rad Laboratories, Inc.
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.7.5 Winning Imperatives
16.7.6 Current Focus & Strategies
16.7.7 Threat from competition
16.8 Qiagen
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.8.5 Winning Imperatives
16.8.6 Current Focus & Strategies
16.8.7 Threat from competition
16.9 Zymo Research Corporation
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.9.5 Winning Imperatives
16.9.6 Current Focus & Strategies
16.9.7 Threat from competition
16.10 Promega Corporation.
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments
16.10.5 Winning Imperatives
16.10.6 Current Focus & Strategies
16.10.7 Threat from competition
16.10.8 SWOT Analysis

LIST OF TABLES 

TABLE 1 Global Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 2 Global Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 3 Global Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 4 Global Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 5 Global Epigenetics Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 6 North America Epigenetics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 7 North America Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 8 North America Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 9 North America Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 10 North America Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 11 US Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 12 US Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 13 US Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 14 US Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 15 Canada Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 16 Canada Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 17 Canada Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 18 Canada Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 19 Mexico Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 20 Mexico Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 21 Mexico Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 22 Mexico Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 23 Europe Epigenetics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 24 Europe Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 25 Europe Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 26 Europe Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 27 Europe Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 28 Germany Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 29 Germany Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 30 Germany Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 31 Germany Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 32 France Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 33 France Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 34 France Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 35 France Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 36 U.K. Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 37 U.K. Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 38 U.K. Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 39 U.K. Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 40 Spain Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 41 Spain Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 42 Spain Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 43 Spain Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 44 Italy Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 45 Italy Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 46 Italy Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 47 Italy Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 48 Russia Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 49 Russia Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 50 Russia Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 51 Russia Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 52 Rest of Europe Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 53 Rest of Europe Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 54 Rest of Europe Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 55 Rest of Europe Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 56 Asia-Pacific Epigenetics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 57 Asia-Pacific Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 58 Asia-Pacific Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 59 Asia-Pacific Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 60 Asia-Pacific Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 61 China Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 62 China Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 63 China Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 64 China Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 65 Japan Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 66 Japan Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 67 Japan Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 68 Japan Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 69 India Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 70 India Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 71 India Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 72 India Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 73 South Korea Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 74 South Korea Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 75 South Korea Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 76 South Korea Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 77 Rest of Asia-Pacific Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 78 Rest of Asia-Pacific Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 79 Rest of Asia-Pacific Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 80 Rest of Asia-Pacific Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 81 Middle East and Africa Epigenetics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 82 Middle East and Africa Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 83 Middle East and Africa Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 84 Middle East and Africa Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 85 Middle East and Africa Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 86 GCC Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 87 GCC Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 88 GCC Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 89 GCC Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 90 North Africa Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 91 North Africa Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 92 North Africa Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 93 North Africa Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 94 South Africa Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 95 South Africa Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 96 South Africa Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 97 South Africa Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 98 Rest of Middle East & Africa Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 99 Rest of Middle East & Africa Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 100 Rest of Middle East & Africa Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 101 Rest of Middle East & Africa Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 102 Latin America Epigenetics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 103 Latin America Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 104 Latin America Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 105 Latin America Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 106 Latin America Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 107 Brazil Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 108 Brazil Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 109 Brazil Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 110 Brazil Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 111 Argentina Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 112 Argentina Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 113 Argentina Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 114 Argentina Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 115 Rest of Latin America Epigenetics Market Revenue, By Products & Services, 2021 – 2031 (USD Million)
TABLE 116 Rest of Latin America Epigenetics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 117 Rest of Latin America Epigenetics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 118 Rest of Latin America Epigenetics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 119 Company Market Ranking
TABLE 120 Regional Footprint
TABLE 121 Application Benchmarking
TABLE 122 Recent Developments
TABLE 123 Winning Imperatives 

LIST OF FIGURES 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Epigenetics Market 2021-2031 (USD Million)
FIG. 4 Global Epigenetics Market Geographical Analysis (CAGR %)
FIG. 5 Global Epigenetics Absolute Market Opportunity (USD Million)
FIG. 6 Global Epigenetics Market Attractiveness (USD Million)
FIG. 7 Global Epigenetics Market, By Products & Services, 2021-2031 (USD Million)
FIG. 8 Global Epigenetics Market, By Application, 2021-2031 (USD Million)
FIG. 9 Global Epigenetics Market, By Technology, 2021-2031 (USD Million)
FIG. 10 Global Epigenetics Market, By End-User, 2021-2031 (USD Million)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Epigenetics Market Revenue Share, By Products & Services, 2021 and 2031 (%)
FIG. 20 Global Epigenetics Market Revenue Share, By Application, 2021 and 2031 (%)
FIG. 21 Global Epigenetics Market Revenue Share, By Technology, 2021 and 2031 (%)
FIG. 22 Global Epigenetics Market Revenue Share, By End-User, 2021 and 2031 (%)
FIG. 23 Global Epigenetics Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 North America Epigenetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Europe Epigenetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Asia-Pacific Epigenetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 31 Middle East & Africa Epigenetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 33 Latin America Epigenetics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Key Strategic Development
FIG. 35 Key Facts
FIG. 36 Financial Overview
FIG. 37 SWOT Analysis